i2 Symposium: DES Update 2010
Monday, March 15, 8:00 AM - 9:30 AM
How do interventionalists stay current on all the exciting research regarding drug-eluting stents (DES)? Well, that is what this session is geared to do!

At ACC.10, there will be late-breaking clinical trials that involve DES, but many of you are still trying to digest the data from the trials discussed at ACC.09. How do you make sense of it all? In this session, expect a nice summary of the key contemporary clinical DES trials and their relevance to current practice.

Also, while DES are the answer to many clinical scenarios, they are not perfect. A better understanding of the mechanism of failure could help the interventionalist choose the right stent for the right patient, as well as improve its delivery. The topics of restenosis and thrombosis round out this session, before the panel gathers to discuss their lectures and attendees' questions

Location: Room B313b

Speaker Information:
David J. Moliterno, MD, Lexington, Ky.
Debabrata Mukherjee, MD, Lexington, Ky.
George D. Dangas, MD, New York
Donald E. Cutlip, MD, Boston

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup